Literature DB >> 11804687

Expression of the MTA1 mRNA in advanced lung cancer.

Hidefumi Sasaki1, Satoru Moriyama, Yoshiaki Nakashima, Yoshihiro Kobayashi, Haruhiro Yukiue, Masahiro Kaji, Ichiro Fukai, Masanobu Kiriyama, Yosuke Yamakawa, Yoshitaka Fujii.   

Abstract

The MTA1 gene is a recently identified metastasis-associated gene which has been implicated in the signal transduction or regulation of gene expression. We examined the mRNA expression levels of the MTA1, the human homologue of the rat mta1 gene in non-small cell lung cancer (NSCLC). Expression of MTA1 messenger RNA was evaluated by reverse transcription polymerase chain reaction (RT-PCR) in 74 non-small cell lung carcinoma samples using LightCycler. The data was analyzed in reference to clinicopathological data. There was no relationship between MTA1 gene expression and age and gender. MTA1/GAPDH mRNA level in stage II-IV NSCLC (3.465+/-3.675) was significantly higher than the level in stage I NSCLC (1.614+/-2.434, P=0.0153). MTA1/GAPDH mRNA levels in T4 NSCLC (4.377+/-4.169) was significantly higher than the level in T1 NSCLC (1.966+/-2.148, P=0.0351) and in T2 NSCLC (2.048+/-1.899, P=0.0269), respectively. MTA1/GAPDH mRNA level in NSCLC with lymph node metastasis (4.242+/-3.758) was significantly higher in NSCLC without lymph node metastasis (P=0.0169). Our results show that the expression of the MTA1 gene is closely related to invasiveness and metastasis in NSCLC. The gene MTA1 could thus potentially provide information on the mechanism of cancer invasion and metastasis.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11804687     DOI: 10.1016/s0169-5002(01)00329-4

Source DB:  PubMed          Journal:  Lung Cancer        ISSN: 0169-5002            Impact factor:   5.705


  33 in total

Review 1.  [Tissue microarrays. High-throughput procedures to verify potential biomarkers].

Authors:  R Kuefer; M D Hofer; J E Gschwend; M A Rubin
Journal:  Urologe A       Date:  2004-06       Impact factor: 0.639

2.  Factors predisposing metastatic tumor antigen 1 overexpression in hepatitis B virus associated hepatocellular carcinoma.

Authors:  Young-Joo Jin; Young-Hwa Chung; Jeong A Kim; Won Hyung Park; Danbi Lee; Dong Dae Seo; Soo Hyung Ryu; Myoung Kuk Jang; Eunsil Yu; Young Joo Lee
Journal:  Dig Dis Sci       Date:  2012-07-10       Impact factor: 3.199

Review 3.  MTA family of transcriptional metaregulators in mammary gland morphogenesis and breast cancer.

Authors:  Rajesh R Singh; Rakesh Kumar
Journal:  J Mammary Gland Biol Neoplasia       Date:  2007-09       Impact factor: 2.673

4.  Involvement of HER-2/neu and metastasis-related proteins in the development of ileal neuroendocrine tumors.

Authors:  Cinzia Azzoni; Lorena Bottarelli; Stefano Cecchini; Costanza Lagrasta; Silvia Pizzi; Tiziana D'Adda; Elisa Tamburini; Guido Rindi; Cesare Bordi
Journal:  Virchows Arch       Date:  2011-03-29       Impact factor: 4.064

5.  A novel peptide (Thx) homing to non-small cell lung cancer identified by ex vivo phage display.

Authors:  A Koivistoinen; I I K Ilonen; K Punakivi; J V Räsänen; H Helin; E I Sihvo; M Bergman; J A Salo
Journal:  Clin Transl Oncol       Date:  2012-11-10       Impact factor: 3.405

6.  Overexpression of MTA1 promotes invasiveness and metastasis of ovarian cancer cells.

Authors:  X He; C Zhou; L Zheng; Z Xiong
Journal:  Ir J Med Sci       Date:  2013-11-10       Impact factor: 1.568

7.  Associations of MTA1 expression with CT features, pathology and prognosis of elderly patients with non-small cell lung cancer.

Authors:  Ning Yang; Chuanming Li; Xiao Han; Zhihua Feng; Feng Qiu; Junqing Han
Journal:  Oncol Lett       Date:  2020-08-28       Impact factor: 2.967

8.  Overexpression of metastatic tumor antigen in osteosarcoma: comparison between conventional high-grade and central low-grade osteosarcoma.

Authors:  Hye-Rim Park; Woon Won Jung; Hyun Sook Kim; Patrizia Bacchini; Franco Bertoni; Yong-Koo Park
Journal:  Cancer Res Treat       Date:  2005-12-31       Impact factor: 4.679

9.  Effect of siRNA targeting MTA1 on metastasis malignant phenotype of ovarian cancer A2780 cells.

Authors:  Yu-Mei Rao; Mei Ji; Cai-Hong Chen; Hui-Rong Shi
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2013-04-17

10.  Repression of Six3 by a corepressor regulates rhodopsin expression.

Authors:  Bramanandam Manavathi; Shaohua Peng; Suresh K Rayala; Amjad H Talukder; Minhua H Wang; Rui-An Wang; Seetharaman Balasenthil; Neeraj Agarwal; Laura J Frishman; Rakesh Kumar
Journal:  Proc Natl Acad Sci U S A       Date:  2007-07-31       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.